These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11593169)

  • 21. Diagnostic value of combining bilateral electrocochleography results for unilateral Ménière's disease.
    Hwang JH; Ho HC; Hsu CJ; Yang WS; Liu TC
    Audiol Neurootol; 2008; 13(6):365-9. PubMed ID: 18525200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of electrocochleography in the diagnosis of Meniere's disease.
    Levine S; Margolis RH; Daly KA
    Laryngoscope; 1998 Jul; 108(7):993-1000. PubMed ID: 9665245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the stage of Meniere's disease using vestibular evoked myogenic potentials.
    Young YH; Huang TW; Cheng PW
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):815-8. PubMed ID: 12925337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of allergy in Meniere's disease.
    Derebery MJ; Berliner KI
    Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 1):69-75. PubMed ID: 10889484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meniere's disease and allergy: allergens and cytokines.
    Keles E; Gödekmerdan A; Kalidağ T; Kaygusuz I; Yalçin S; Cengiz Alpay H; Aral M
    J Laryngol Otol; 2004 Sep; 118(9):688-93. PubMed ID: 15509365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrocochleography in retrosigmoid vestibular nerve section for intractable vertigo caused by Menière's disease.
    Krueger WW; Storper IS
    Otolaryngol Head Neck Surg; 1997 Jun; 116(6 Pt 1):593-6. PubMed ID: 9215368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière's disease: a clinical placebo-controlled study.
    Densert B; Densert O; Arlinger S; Sass K; Odkvist L
    Am J Otol; 1997 Nov; 18(6):726-33. PubMed ID: 9391668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of static middle-ear and intracranial pressure changes on differential electrocochleographic response.
    Franz B; Anderson C
    Int Tinnitus J; 2008; 14(2):101-7. PubMed ID: 19205159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplitude and area ratios of summating potential/action potential (SP/AP) in Meniere's disease.
    Baba A; Takasaki K; Tanaka F; Tsukasaki N; Kumagami H; Takahashi H
    Acta Otolaryngol; 2009 Jan; 129(1):25-9. PubMed ID: 19003588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of condensation and rarefaction click evoked action potential latency difference in the diagnosis of Meniere's disease].
    Wang Z; Shao X; Yan W; Lin H
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Jun; 35(3):211-4. PubMed ID: 12768780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of vestibular rehabilitation in the treatment of Meniere's disease.
    Gottshall KR; Hoffer ME; Moore RJ; Balough BJ
    Otolaryngol Head Neck Surg; 2005 Sep; 133(3):326-8. PubMed ID: 16143175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergic and immunologic features of Ménière's disease.
    Derebery MJ
    Otolaryngol Clin North Am; 2011 Jun; 44(3):655-66, ix. PubMed ID: 21621052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrocochleography in patients with Meniere's disease.
    Kim HH; Kumar A; Battista RA; Wiet RJ
    Am J Otolaryngol; 2005; 26(2):128-31. PubMed ID: 15742267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vestibular evoked myogenic potentials in acute low-tone sensorineural hearing loss.
    Wu CL; Young YH
    Laryngoscope; 2004 Dec; 114(12):2172-5. PubMed ID: 15564839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum antidiuretic hormone levels in patients with unilateral Meniere's disease.
    Lim JS; Lange ME; Megerian CA
    Laryngoscope; 2003 Aug; 113(8):1321-6. PubMed ID: 12897553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Audiologic measure in Ménière's disease].
    Zhong N; Wang H
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Apr; 32(2):73-6. PubMed ID: 10743131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.